ROMAPHARM
ActiveSummary
ROMAPHARM has been active since 1995 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.3m and a net result of €140,883. Equity is growing by ~11.8% per year across the filed fiscal years. Its solvency ranks better than 87% of 10485 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability75▼-2
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €180,000 at 30 days acceptable
Liquidity ample (current ratio 2.96 against 2.02 in 2024; short-term debt: 13.9% and cash: 11.6% of total assets), and 23% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
77%
Return on assets
4.8%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 10-06-2026, 51 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
51 d early
2024
103 d early
2023
89 d early
2022
98 d early
2021
31 d early
2020
51 d early
2019
59 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 69 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 46% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Public money How does this company compare with its sector?Sector benchmark
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
In the rankings
#3 company by equity in Koksijde, Wholesale and retail trade sector#10 company by total assets in Koksijde, Wholesale and retail trade sector
Equity
€2.3m▲ 6.6%
2024 · €2.1m
Total assets
€3.0m▲ 3.2%
2024 · €2.9m
Net result
€140,883▼ 27.4%
2024 · €194,092
Working capital
€808,935▲ 69.3%
2024 · €477,817
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€251,784▲ 30.6%€263,837▲ 4.8%€340,954▲ 29.2%€259,350▼ 23.9%€192,573▼ 25.7%
Net result€189,493above the sector's middle half▲ 27.3%€199,921above the sector's middle half▲ 5.5%€257,112above the sector's middle half▲ 28.6%€194,092above the sector's middle half▼ 24.5%€140,883above the sector's middle half▼ 27.4%
Equity€1.5mabove the sector's middle half▲ 14.6%€1.7mabove the sector's middle half▲ 13.4%€1.9mabove the sector's middle half▲ 15.2%€2.1mabove the sector's middle half▲ 10.0%€2.3mabove the sector's middle half▲ 6.6%
Total assets€2.4mabove the sector's middle half▲ 11.4%€2.6mabove the sector's middle half▲ 5.4%€2.6mabove the sector's middle half▲ 2.2%€2.9mabove the sector's middle half▲ 9.6%€3.0mabove the sector's middle half▲ 3.2%
Debt€937,612▲ 7.0%€869,723▼ 7.2%€671,160▼ 22.8%€730,050▲ 8.8%€682,312▼ 6.5%
Working capital€1.2m▲ 37.5%€316,062▼ 73.7%€411,099▲ 30.1%€477,817▲ 16.2%€808,935▲ 69.3%
Solvency61.2%above the sector's middle half▲ 1.7pp65.9%above the sector's middle half▲ 4.7pp74.3%above the sector's middle half▲ 8.4pp74.5%above the sector's middle half▲ 0.3pp77.0%above the sector's middle half▲ 2.4pp
Staff (FTE)8.5above the sector's middle half▲ 6.3%7.3within the sector's middle half▼ 14.1%7.3within the sector's middle half=5.3within the sector's middle half▼ 27.4%5.6within the sector's middle half▲ 5.7%
above
within
below
the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 26% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €3.0m
Fixed assets
€1.7m ▼ 9.4%
Current assets
€1.2m ▲ 28.8%
Equity and liabilities €3.0m
Equity
€2.3m ▲ 6.6%
Provisions
€0 ▼ 100%
Debt
€682,312 ▼ 6.5%
Debt's share of the balance-sheet total falls from 25.4% to 23.0%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€301,140▼
2024 · €369,716
Cash flow
€249,449▼
2024 · €304,458
Current ratio
2.96▲
2024 · 2.02
Quick ratio
2.01▲
2024 · 1.16
Debt to equity
0.30▼
2024 · 0.34
ROE
6.2%▼
2024 · 9.1%
ROA
4.8%▼
2024 · 6.8%
Interest coverage
143.72▼
2024 · 262.45
Debt ≤ 1 year
€412,450▼
2024 · €470,627
Debt > 1 year
€269,514▲
2024 · €259,424
Income taxes
€52,292▼
2024 · €66,700
Staff costs
€283,821▼
2024 · €285,974
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 17,027 companies that looked in July 2024 the way this one looks now, 0.5% went bankrupt within 24 months and 94% are still going.
- Micro
- 20 years or older
- solvency 30% or more
- a profit under 5% of the balance sheet
0.5%
went bankrupt
4.9%
stopped otherwise
94%
still going
A further 0.3% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 0.6% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 17,027 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | €451,616 | €368,372 | €269,971 | €285,974 | €283,821 | ▼ 0.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €105,892 | €105,886 | €105,323 | €110,365 | €108,567 | ▼ 1.6% |
| Other operating charges640/8 | €17,029 | €16,765 | €20,153 | €19,709 | €20,314 | ▲ 3.1% |
| Gross operating margin9900 | €826,320 | €754,859 | €736,402 | €675,398 | €605,275 | ▼ 10.4% |
| Operating profit (loss)9901 | €251,784 | €263,837 | €340,954 | €259,350 | €192,573 | ▼ 25.7% |
| Financial income75/76B | €1,687 | €1,467 | €650 | €1,236 | €1,082 | ▼ 12.5% |
| Recurring financial income75 | €1,687 | €1,467 | €650 | €1,236 | €1,082 | ▼ 12.5% |
| Financial charges65/66B | €2,901 | €2,133 | €1,605 | €1,409 | €2,095 | ▲ 48.7% |
| Recurring financial charges65 | €2,901 | €2,133 | €1,605 | €1,409 | €2,095 | ▲ 48.7% |
| Profit (loss) for the period before taxes9903 | €250,570 | €263,170 | €339,999 | €259,177 | €191,559 | ▼ 26.1% |
| Transfer from deferred taxes780 | €1,615 | €1,615 | €1,615 | €1,615 | €1,615 | = |
| Income taxes67/77 | €62,692 | €64,865 | €84,502 | €66,700 | €52,292 | ▼ 21.6% |
| Profit (loss) for the period9904 | €189,493 | €199,921 | €257,112 | €194,092 | €140,883 | ▼ 27.4% |
| Transfer from tax-exempt reserves789 | €3,136 | €3,136 | €3,136 | €3,136 | €3,136 | = |
| Profit (loss) for the period to be appropriated9905 | €192,629 | €203,057 | €260,248 | €197,228 | €144,019 | ▼ 27.0% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €2.4m | €2.6m | €2.6m | €2.9m | €3.0m | ▲ 3.2% |
| Fixed assets21/28 | €694,935 | €1.8m | €1.8m | €1.9m | €1.7m | ▼ 9.4% |
| Tangible fixed assets22/27 | €694,687 | €588,802 | €483,478 | €390,720 | €282,153 | ▼ 27.8% |
| Land and buildings22 | €694,687 | €588,802 | €483,478 | €378,155 | €275,457 | ▼ 27.2% |
| Furniture and vehicles24 | - | - | - | €12,565 | €6,696 | ▼ 46.7% |
| Financial fixed assets28 | €248 | €1.2m | €1.3m | €1.5m | €1.5m | ▼ 4.7% |
| Current assets29/58 | €1.7m | €741,599 | €806,986 | €948,443 | €1.2m | ▲ 28.8% |
| Amounts receivable after more than one year29 | €790,636 | €0 | - | - | - | - |
| Other amounts receivable291 | €790,636 | €0 | - | - | - | - |
| Stocks and contracts in progress3 | €388,835 | €365,146 | €381,905 | €402,779 | €393,063 | ▼ 2.4% |
| Stocks30/36 | €388,835 | €365,146 | €381,905 | €402,779 | €393,063 | ▼ 2.4% |
| Amounts receivable within one year40/41 | €259,114 | €241,077 | €240,043 | €395,030 | €463,247 | ▲ 17.3% |
| Trade receivables40 | €259,113 | €239,757 | €236,975 | €381,111 | €429,533 | ▲ 12.7% |
| Other amounts receivable41 | €0 | €1,319 | €3,069 | €13,919 | €33,714 | ▲ 142% |
| Current investments50/53 | €113,173 | €5,444 | €30,403 | €5,412 | €16,415 | ▲ 203% |
| Cash at bank and in hand54/58 | €184,562 | €127,855 | €151,347 | €140,972 | €344,630 | ▲ 144% |
| Deferred charges and accrued income490/1 | €4,406 | €2,078 | €3,288 | €4,250 | €4,032 | ▼ 5.1% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €2.4m | €2.6m | €2.6m | €2.9m | €3.0m | ▲ 3.2% |
| Equity10/15 | €1.5m | €1.7m | €1.9m | €2.1m | €2.3m | ▲ 6.6% |
| Contributions10/11 | €172,000 | €172,000 | €172,000 | €172,000 | €172,000 | = |
| Capital10 | €172,000 | €172,000 | €172,000 | €172,000 | €172,000 | = |
| Issued capital100 | €172,000 | €172,000 | €172,000 | €172,000 | €172,000 | = |
| Reserves13 | €1.3m | €1.5m | €1.8m | €2.0m | €2.1m | ▲ 7.1% |
| Non-distributable reserves130/1 | €17,200 | €17,200 | €17,200 | €17,200 | €17,200 | = |
| Legal reserve130 | €17,200 | €17,200 | €17,200 | €17,200 | €17,200 | = |
| Tax-exempt reserves132 | €61,006 | €57,870 | €54,734 | €51,598 | €48,461 | ▼ 6.1% |
| Distributable reserves133 | €1.2m | €1.4m | €1.7m | €1.9m | €2.0m | ▲ 7.6% |
| Profit (loss) carried forward14 | €382 | €438 | €686 | €414 | €433 | ▲ 4.5% |
| Provisions and deferred taxes16 | €6,459 | €4,845 | €3,230 | €1,615 | €0 | ▼ 100% |
| Deferred taxes168 | €6,459 | €4,845 | €3,230 | €1,615 | €0 | ▼ 100% |
| Amounts payable17/49 | €937,612 | €869,723 | €671,160 | €730,050 | €682,312 | ▼ 6.5% |
| Amounts payable after more than one year17 | €389,490 | €439,324 | €274,715 | €259,424 | €269,514 | ▲ 3.9% |
| Other amounts payable178/9 | €389,490 | €439,324 | €274,715 | €259,424 | €269,514 | ▲ 3.9% |
| Amounts payable within one year42/48 | €539,404 | €425,537 | €395,887 | €470,627 | €412,450 | ▼ 12.4% |
| Financial debts43 | €67,226 | €8,750 | €0 | - | - | - |
| Credit institutions430/8 | €67,226 | €8,750 | €0 | - | - | - |
| Trade debts44 | €342,052 | €290,014 | €297,730 | €403,273 | €358,819 | ▼ 11.0% |
| Suppliers440/4 | €342,052 | €290,014 | €297,730 | €403,273 | €358,819 | ▼ 11.0% |
| Advances received on contracts in progress46 | €973 | €0 | - | €725 | €0 | ▼ 100% |
| Taxes, remuneration and social security45 | €129,153 | €113,554 | €64,965 | €66,629 | €53,631 | ▼ 19.5% |
| Taxes450/3 | €52,152 | €46,721 | €19,281 | €21,418 | €6,215 | ▼ 71.0% |
| Remuneration and social security454/9 | €77,000 | €66,834 | €45,683 | €45,211 | €47,416 | ▲ 4.9% |
| Other amounts payable47/48 | - | €13,218 | €33,192 | €0 | - | - |
| Accrued charges and deferred income492/3 | €8,718 | €4,862 | €558 | €0 | €348 | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €189,493 | €199,921 | €257,112 | €194,092 | €140,883 | ▼ 27.4% |
| + Depreciation and write-downs630 | €105,892 | €105,886 | €105,323 | €110,365 | €108,567 | ▼ 1.6% |
| Operating cash flow (approximation) | €295,385 | €305,806 | €362,435 | €304,458 | €249,449 | ▼ 18.1% |
| Investment in fixed assets (approximation) | - | -€1.2m | -€96,870 | -€220,276 | €72,846 | ▲ 133% |
| Change in cash | - | -€56,707 | €23,492 | -€10,374 | €203,657 | ▲ 2,063% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
10-06
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
19-04
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Equity above €2mEq €2.1m ▲10%
7 profitable years in a row build equity to €2.1m.
03-05
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial
Highest result since 2018net €257,112 ▲28.6%
Operating result €340,954, net result €257,112, both a record.
24-04
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
30-06
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
10-06
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
02-06
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
06-06
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
16-07
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
13-07
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 4 acts read
About the unread acts
We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Koksijde · 3 establishment units since 1996
Ground area
1,237 m²
Building footprint
431 m²
Volume, LiDAR
4,695 m³
3 parcels, Flanders · tallest building 20.5 m, ±6 floors. Linked by address, not a title deed.
3 establishment units
ROMAPHARM NV
since 19962.074.897.306
ROMAPHARM NV
since 19962.074.897.405
ROMAPHARM
since 20022.074.897.603
3 parcels
Flanders
3
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 38342H0682/00D000 | Flanders | 921 m² | 1 · 146 m² | 11.0 m · 2 fl. |
| 38342G0052/00A000 | Flanders | 195 m² | 1 · 166 m² | 20.1 m · 6 fl. |
| 38342G0054/00C000 | Flanders | 121 m² | 1 · 119 m² | 20.5 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
3 of 3 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2022 · 1 entry · 1,859 EUR awarded · 1,859 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2022 | 1 | 1,859 EUR | 1,859 EUR |
Recognitions · licences · registrations
Food safety, FASFC
2 sitesKoksijde2.074.897.306
Koksijde2.074.897.603
Similar companies · same sector, comparable size
JECO FARMA
BE 0892.081.482
Brakel · Eq €2,262,956
Apotheek PHARMANOVA
BE 0420.297.040
Houthulst · Eq €2,305,259
LINAPO
BE 0471.958.349
Lubbeek · Eq €2,307,166
APOTHEEK MIEKE BOUTTELISIER
BE 0456.458.541
Roeselare · Eq €2,257,440
FARMAZORG
BE 0828.830.158
Oudenburg · Eq €2,326,911
Of 5,220 companies in sector 47730 we hold annual accounts for 3,862. 2,198 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPublic limited company
Founded22-12-1995
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
68201Renting and operating of own or leased residential real estate, excluding social housing
E-invoicing
Reachable via Peppol
Peppol ID
0208:0456909689
Also
9925:BE0456909689
Registered
24-09-2025
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.